Quantitative Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Quantitative Investment Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-715	Closed	-$353K	–	277
2022 Q2	$353K	Buy	+715	New	+$372K	0.05%	176
2022 Q1	–	Sell	-620	Closed	-$468K	–	207
2021 Q4	$468K	Sell	620 -1,203	-66%	-$900K	0.07%	177
2021 Q3	$1.36M	Sell	1,823 -663	-27%	-$497K	0.12%	164
2021 Q2	$1.6M	Buy	+2,486	New	+$1.51M	0.14%	144
2020 Q4	–	Sell	-626	Closed	-$322K	–	462
2020 Q3	$322K	Sell	626 -984	-61%	-$498K	0.03%	309
2020 Q2	$726K	Buy	+1,610	New	+$710K	0.07%	267
2020 Q1	–	Sell	-2,481	Closed	-$918K	–	526
2019 Q4	$918K	Buy	+2,481	New	+$875K	0.03%	450
2018 Q3	–	Sell	-8,300	Closed	-$2.39M	–	648
2018 Q2	$2.39M	Buy	+8,300	New	+$2.29M	0.05%	334

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Quantitative Investment Management's BIO Position: Q3 2022 in Review

Quantitative Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 715 shares — an estimated $353K sold.

Quantitative Investment Management first reported a position in BIO in Q2 2018 and held it in 8 quarters. The position peaked at $2.39M in Q2 2018. 484 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

Quantitative Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
Quantitative Investment Management sold 715 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $353K.
Quantitative Investment Management first reported a position in Bio-Rad Laboratories Class A in Q2 2018 and held it in 8 quarters.
Quantitative Investment Management's Bio-Rad Laboratories Class A position peaked at $2.39M in Q2 2018.
484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on Quantitative Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.